We serve Chemical Name:fmoc-(r)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid CAS:269396-60-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:fmoc-(r)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid
CAS.NO:269396-60-3
Synonyms:fmoc-(r)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid
Molecular Formula:C25H21F2NO4
Molecular Weight:437.43500
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:635.8ºC at 760mmHg
Density:1.332g/cm3
Index of Refraction:1.604
PSA:75.63000
Exact Mass:437.14400
LogP:5.28020
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like fmoc-(r)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,fmoc-(r)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,fmoc-(r)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid Use and application,fmoc-(r)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid technical grade,usp/ep/jp grade.
Related News: Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. fmoc-(r)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid manufacturer He was the partner of a 38-year-old Chinese woman who was travelling with him. She was the first confirmed case reported in the Philippines. fmoc-(r)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid supplier The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs. fmoc-(r)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid vendor The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs. fmoc-(r)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid factory Like Altasciences, Alira has also placed an emphasis on the preclinical setting in recent months with its March hire of Nikole Siegmund as vice president of preclinical development.
